▶ 調査レポート

内視鏡的逆行性胆管膵管造影の世界市場 2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Endoscopic Retrograde Cholangiopancreatography Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。内視鏡的逆行性胆管膵管造影の世界市場 2020年:企業別、地域別、種類・用途別 / Global Endoscopic Retrograde Cholangiopancreatography Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / D005-00367資料のイメージです。• レポートコード:D005-00367
• 出版社/出版日:GlobalInfoResearch / 2020年5月29日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、101ページ
• 納品方法:Eメール
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、内視鏡的逆行性胆管膵管造影の世界市場を広く調査・分析し、今後の市場展望をまとめております。内視鏡的逆行性胆管膵管造影の種類別市場規模(内視鏡的括約筋切開術、石&他胆汁破片除去、胆管ステント挿入、狭窄拡張)、用途別市場規模(病院、クリニック、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Johnson & Johnson、Becton Dickinson、CONMED、Boston Scientific、Ethicon、Medtronic、Cook、Fujifilm、Stryker、B.Braun Melsungen
・地域別グローバル市場分析 2015年-2020年
・内視鏡的逆行性胆管膵管造影の北米市場(アメリカ、カナダ、メキシコ)
・内視鏡的逆行性胆管膵管造影のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・内視鏡的逆行性胆管膵管造影のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・内視鏡的逆行性胆管膵管造影の南米市場(ブラジル、アルゼンチン)
・内視鏡的逆行性胆管膵管造影の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:内視鏡的括約筋切開術、石&他胆汁破片除去、胆管ステント挿入、狭窄拡張
・用途別分析:病院、クリニック、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Endoscopic Retrograde Cholangiopancreatography market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.2% in the forecast period of 2020 to 2025 and will expected to reach USD 19600 million by 2025, from USD 16620 million in 2019.

The Endoscopic Retrograde Cholangiopancreatography market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Endoscopic Retrograde Cholangiopancreatography market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Endoscopic Retrograde Cholangiopancreatography market has been segmented into:
Endoscopic sphincterotomy
Removal of stones or other biliary debris
Insertion of bile duct stent(s)
Dilation of strictures

By Application, Endoscopic Retrograde Cholangiopancreatography has been segmented into:
Hospitals
Clinics
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Endoscopic Retrograde Cholangiopancreatography market presented in the report. This section sheds light on the sales growth of different regional and country-level Endoscopic Retrograde Cholangiopancreatography markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Endoscopic Retrograde Cholangiopancreatography market.

The report offers in-depth assessment of the growth and other aspects of the Endoscopic Retrograde Cholangiopancreatography market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Endoscopic Retrograde Cholangiopancreatography Market Share Analysis
Endoscopic Retrograde Cholangiopancreatography competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Endoscopic Retrograde Cholangiopancreatography sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Endoscopic Retrograde Cholangiopancreatography sales, revenue and market share for each player covered in this report.

The major players covered in Endoscopic Retrograde Cholangiopancreatography are:
Johnson & Johnson
Becton Dickinson
CONMED
Boston Scientific
Ethicon
Medtronic
Cook
Fujifilm
Stryker
B.Braun Melsungen

レポート目次

Table of Contents

1 Endoscopic Retrograde Cholangiopancreatography Market Overview
1.1 Product Overview and Scope of Endoscopic Retrograde Cholangiopancreatography
1.2 Classification of Endoscopic Retrograde Cholangiopancreatography by Type
1.2.1 Global Endoscopic Retrograde Cholangiopancreatography Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Type in 2019
1.2.3 Endoscopic sphincterotomy
1.2.4 Removal of stones or other biliary debris
1.2.5 Insertion of bile duct stent(s)
1.2.6 Dilation of strictures
1.3 Global Endoscopic Retrograde Cholangiopancreatography Market by Application
1.3.1 Overview: Global Endoscopic Retrograde Cholangiopancreatography Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Endoscopic Retrograde Cholangiopancreatography Market by Regions
1.4.1 Global Endoscopic Retrograde Cholangiopancreatography Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Endoscopic Retrograde Cholangiopancreatography (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Endoscopic Retrograde Cholangiopancreatography Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Endoscopic Retrograde Cholangiopancreatography Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Endoscopic Retrograde Cholangiopancreatography Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Endoscopic Retrograde Cholangiopancreatography Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Endoscopic Retrograde Cholangiopancreatography Status and Prospect (2015-2025)
2 Company Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Johnson & Johnson SWOT Analysis
2.1.4 Johnson & Johnson Product and Services
2.1.5 Johnson & Johnson Endoscopic Retrograde Cholangiopancreatography Revenue, Gross Margin and Market Share (2018-2019)
2.2 Becton Dickinson
2.2.1 Becton Dickinson Details
2.2.2 Becton Dickinson Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Becton Dickinson SWOT Analysis
2.2.4 Becton Dickinson Product and Services
2.2.5 Becton Dickinson Endoscopic Retrograde Cholangiopancreatography Revenue, Gross Margin and Market Share (2018-2019)
2.3 CONMED
2.3.1 CONMED Details
2.3.2 CONMED Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 CONMED SWOT Analysis
2.3.4 CONMED Product and Services
2.3.5 CONMED Endoscopic Retrograde Cholangiopancreatography Revenue, Gross Margin and Market Share (2018-2019)
2.4 Boston Scientific
2.4.1 Boston Scientific Details
2.4.2 Boston Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Boston Scientific SWOT Analysis
2.4.4 Boston Scientific Product and Services
2.4.5 Boston Scientific Endoscopic Retrograde Cholangiopancreatography Revenue, Gross Margin and Market Share (2018-2019)
2.5 Ethicon
2.5.1 Ethicon Details
2.5.2 Ethicon Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Ethicon SWOT Analysis
2.5.4 Ethicon Product and Services
2.5.5 Ethicon Endoscopic Retrograde Cholangiopancreatography Revenue, Gross Margin and Market Share (2018-2019)
2.6 Medtronic
2.6.1 Medtronic Details
2.6.2 Medtronic Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Medtronic SWOT Analysis
2.6.4 Medtronic Product and Services
2.6.5 Medtronic Endoscopic Retrograde Cholangiopancreatography Revenue, Gross Margin and Market Share (2018-2019)
2.7 Cook
2.7.1 Cook Details
2.7.2 Cook Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Cook SWOT Analysis
2.7.4 Cook Product and Services
2.7.5 Cook Endoscopic Retrograde Cholangiopancreatography Revenue, Gross Margin and Market Share (2018-2019)
2.8 Fujifilm
2.8.1 Fujifilm Details
2.8.2 Fujifilm Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Fujifilm SWOT Analysis
2.8.4 Fujifilm Product and Services
2.8.5 Fujifilm Endoscopic Retrograde Cholangiopancreatography Revenue, Gross Margin and Market Share (2018-2019)
2.9 Stryker
2.9.1 Stryker Details
2.9.2 Stryker Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Stryker SWOT Analysis
2.9.4 Stryker Product and Services
2.9.5 Stryker Endoscopic Retrograde Cholangiopancreatography Revenue, Gross Margin and Market Share (2018-2019)
2.10 B.Braun Melsungen
2.10.1 B.Braun Melsungen Details
2.10.2 B.Braun Melsungen Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 B.Braun Melsungen SWOT Analysis
2.10.4 B.Braun Melsungen Product and Services
2.10.5 B.Braun Melsungen Endoscopic Retrograde Cholangiopancreatography Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Endoscopic Retrograde Cholangiopancreatography Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Endoscopic Retrograde Cholangiopancreatography Players Market Share
3.2.2 Top 10 Endoscopic Retrograde Cholangiopancreatography Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Endoscopic Retrograde Cholangiopancreatography Revenue and Market Share by Regions
4.2 North America Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
4.3 Europe Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
4.5 South America Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
5 North America Endoscopic Retrograde Cholangiopancreatography Revenue by Countries
5.1 North America Endoscopic Retrograde Cholangiopancreatography Revenue by Countries (2015-2020)
5.2 USA Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
5.3 Canada Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
5.4 Mexico Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
6 Europe Endoscopic Retrograde Cholangiopancreatography Revenue by Countries
6.1 Europe Endoscopic Retrograde Cholangiopancreatography Revenue by Countries (2015-2020)
6.2 Germany Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
6.3 UK Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
6.4 France Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
6.5 Russia Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
6.6 Italy Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Revenue by Countries
7.1 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Revenue by Countries (2015-2020)
7.2 China Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
7.3 Japan Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
7.4 Korea Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
7.5 India Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
8 South America Endoscopic Retrograde Cholangiopancreatography Revenue by Countries
8.1 South America Endoscopic Retrograde Cholangiopancreatography Revenue by Countries (2015-2020)
8.2 Brazil Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
8.3 Argentina Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Endoscopic Retrograde Cholangiopancreatography by Countries
9.1 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Revenue by Countries (2015-2020)
9.2 Saudi Arabia Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
9.3 UAE Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
9.4 Egypt Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
9.5 South Africa Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Endoscopic Retrograde Cholangiopancreatography Revenue and Market Share by Type (2015-2020)
10.2 Global Endoscopic Retrograde Cholangiopancreatography Market Forecast by Type (2019-2024)
10.3 Endoscopic sphincterotomy Revenue Growth Rate (2015-2025)
10.4 Removal of stones or other biliary debris Revenue Growth Rate (2015-2025)
10.5 Insertion of bile duct stent(s) Revenue Growth Rate (2015-2025)
10.6 Dilation of strictures Revenue Growth Rate (2015-2025)
11 Global Endoscopic Retrograde Cholangiopancreatography Market Segment by Application
11.1 Global Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Application (2015-2020)
11.2 Endoscopic Retrograde Cholangiopancreatography Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Endoscopic Retrograde Cholangiopancreatography Market Size Forecast (2021-2025)
12.1 Global Endoscopic Retrograde Cholangiopancreatography Market Size Forecast (2021-2025)
12.2 Global Endoscopic Retrograde Cholangiopancreatography Market Forecast by Regions (2021-2025)
12.3 North America Endoscopic Retrograde Cholangiopancreatography Revenue Market Forecast (2021-2025)
12.4 Europe Endoscopic Retrograde Cholangiopancreatography Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Revenue Market Forecast (2021-2025)
12.6 South America Endoscopic Retrograde Cholangiopancreatography Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Endoscopic Retrograde Cholangiopancreatography Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Endoscopic Retrograde Cholangiopancreatography by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Endoscopic Retrograde Cholangiopancreatography Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Endoscopic Retrograde Cholangiopancreatography Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Johnson & Johnson Corporate Information, Location and Competitors
Table 6. Johnson & Johnson Endoscopic Retrograde Cholangiopancreatography Major Business
Table 7. Johnson & Johnson Endoscopic Retrograde Cholangiopancreatography Total Revenue (USD Million) (2017-2018)
Table 8. Johnson & Johnson SWOT Analysis
Table 9. Johnson & Johnson Endoscopic Retrograde Cholangiopancreatography Product and Solutions
Table 10. Johnson & Johnson Endoscopic Retrograde Cholangiopancreatography Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Becton Dickinson Corporate Information, Location and Competitors
Table 12. Becton Dickinson Endoscopic Retrograde Cholangiopancreatography Major Business
Table 13. Becton Dickinson Endoscopic Retrograde Cholangiopancreatography Total Revenue (USD Million) (2018-2019)
Table 14. Becton Dickinson SWOT Analysis
Table 15. Becton Dickinson Endoscopic Retrograde Cholangiopancreatography Product and Solutions
Table 16. Becton Dickinson Endoscopic Retrograde Cholangiopancreatography Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. CONMED Corporate Information, Location and Competitors
Table 18. CONMED Endoscopic Retrograde Cholangiopancreatography Major Business
Table 19. CONMED Endoscopic Retrograde Cholangiopancreatography Total Revenue (USD Million) (2017-2018)
Table 20. CONMED SWOT Analysis
Table 21. CONMED Endoscopic Retrograde Cholangiopancreatography Product and Solutions
Table 22. CONMED Endoscopic Retrograde Cholangiopancreatography Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Boston Scientific Corporate Information, Location and Competitors
Table 24. Boston Scientific Endoscopic Retrograde Cholangiopancreatography Major Business
Table 25. Boston Scientific Endoscopic Retrograde Cholangiopancreatography Total Revenue (USD Million) (2017-2018)
Table 26. Boston Scientific SWOT Analysis
Table 27. Boston Scientific Endoscopic Retrograde Cholangiopancreatography Product and Solutions
Table 28. Boston Scientific Endoscopic Retrograde Cholangiopancreatography Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Ethicon Corporate Information, Location and Competitors
Table 30. Ethicon Endoscopic Retrograde Cholangiopancreatography Major Business
Table 31. Ethicon Endoscopic Retrograde Cholangiopancreatography Total Revenue (USD Million) (2017-2018)
Table 32. Ethicon SWOT Analysis
Table 33. Ethicon Endoscopic Retrograde Cholangiopancreatography Product and Solutions
Table 34. Ethicon Endoscopic Retrograde Cholangiopancreatography Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Medtronic Corporate Information, Location and Competitors
Table 36. Medtronic Endoscopic Retrograde Cholangiopancreatography Major Business
Table 37. Medtronic Endoscopic Retrograde Cholangiopancreatography Total Revenue (USD Million) (2017-2018)
Table 38. Medtronic SWOT Analysis
Table 39. Medtronic Endoscopic Retrograde Cholangiopancreatography Product and Solutions
Table 40. Medtronic Endoscopic Retrograde Cholangiopancreatography Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Cook Corporate Information, Location and Competitors
Table 42. Cook Endoscopic Retrograde Cholangiopancreatography Major Business
Table 43. Cook Endoscopic Retrograde Cholangiopancreatography Total Revenue (USD Million) (2017-2018)
Table 44. Cook SWOT Analysis
Table 45. Cook Endoscopic Retrograde Cholangiopancreatography Product and Solutions
Table 46. Cook Endoscopic Retrograde Cholangiopancreatography Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Fujifilm Corporate Information, Location and Competitors
Table 48. Fujifilm Endoscopic Retrograde Cholangiopancreatography Major Business
Table 49. Fujifilm Endoscopic Retrograde Cholangiopancreatography Total Revenue (USD Million) (2017-2018)
Table 50. Fujifilm SWOT Analysis
Table 51. Fujifilm Endoscopic Retrograde Cholangiopancreatography Product and Solutions
Table 52. Fujifilm Endoscopic Retrograde Cholangiopancreatography Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Stryker Corporate Information, Location and Competitors
Table 54. Stryker Endoscopic Retrograde Cholangiopancreatography Major Business
Table 55. Stryker Endoscopic Retrograde Cholangiopancreatography Total Revenue (USD Million) (2017-2018)
Table 56. Stryker SWOT Analysis
Table 57. Stryker Endoscopic Retrograde Cholangiopancreatography Product and Solutions
Table 58. Stryker Endoscopic Retrograde Cholangiopancreatography Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. B.Braun Melsungen Corporate Information, Location and Competitors
Table 60. B.Braun Melsungen Endoscopic Retrograde Cholangiopancreatography Major Business
Table 61. B.Braun Melsungen Endoscopic Retrograde Cholangiopancreatography Total Revenue (USD Million) (2017-2018)
Table 62. B.Braun Melsungen SWOT Analysis
Table 63. B.Braun Melsungen Endoscopic Retrograde Cholangiopancreatography Product and Solutions
Table 64. B.Braun Melsungen Endoscopic Retrograde Cholangiopancreatography Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Endoscopic Retrograde Cholangiopancreatography Revenue (Million USD) by Players (2015-2020)
Table 66. Global Endoscopic Retrograde Cholangiopancreatography Revenue Share by Players (2015-2020)
Table 67. Global Endoscopic Retrograde Cholangiopancreatography Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Regions (2015-2020)
Table 69. North America Endoscopic Retrograde Cholangiopancreatography Revenue by Countries (2015-2020)
Table 70. North America Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Countries (2015-2020)
Table 71. Europe Endoscopic Retrograde Cholangiopancreatography Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Endoscopic Retrograde Cholangiopancreatography Revenue by Countries (2015-2020)
Table 74. South America Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Countries (2015-2020)
Table 77. Global Endoscopic Retrograde Cholangiopancreatography Revenue (Million USD) by Type (2015-2020)
Table 78. Global Endoscopic Retrograde Cholangiopancreatography Revenue Share by Type (2015-2020)
Table 79. Global Endoscopic Retrograde Cholangiopancreatography Revenue Forecast by Type (2021-2025)
Table 80. Global Endoscopic Retrograde Cholangiopancreatography Revenue by Application (2015-2020)
Table 81. Global Endoscopic Retrograde Cholangiopancreatography Revenue Share by Application (2015-2020)
Table 82. Global Endoscopic Retrograde Cholangiopancreatography Revenue Forecast by Application (2021-2025)
Table 83. Global Endoscopic Retrograde Cholangiopancreatography Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Endoscopic Retrograde Cholangiopancreatography Picture
Figure 2. Global Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Type in 2019
Figure 3. Endoscopic sphincterotomy Picture
Figure 4. Removal of stones or other biliary debris Picture
Figure 5. Insertion of bile duct stent(s) Picture
Figure 6. Dilation of strictures Picture
Figure 7. Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Others Picture
Figure 11. Global Endoscopic Retrograde Cholangiopancreatography Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Endoscopic Retrograde Cholangiopancreatography Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Endoscopic Retrograde Cholangiopancreatography Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Endoscopic Retrograde Cholangiopancreatography Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Endoscopic Retrograde Cholangiopancreatography Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Endoscopic Retrograde Cholangiopancreatography Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Endoscopic Retrograde Cholangiopancreatography Revenue Market Share in 2019
Figure 20. Global Top 10 Players Endoscopic Retrograde Cholangiopancreatography Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Endoscopic Retrograde Cholangiopancreatography Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Regions (2015-2020)
Figure 24. Global Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Regions in 2018
Figure 25. North America Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
Figure 26. Europe Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
Figure 28. South America Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
Figure 30. North America Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Countries (2015-2020)
Figure 31. North America Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Countries in 2019
Figure 32. USA Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
Figure 33. Canada Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
Figure 35. Europe Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Countries in 2019
Figure 37. Germany Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
Figure 38. UK Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
Figure 39. France Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
Figure 40. Russia Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
Figure 41. Italy Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Countries in 2019
Figure 44. China Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
Figure 45. Japan Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
Figure 46. Korea Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
Figure 47. India Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
Figure 49. South America Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Countries (2015-2020)
Figure 50. South America Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Countries in 2019
Figure 51. Brazil Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
Figure 56. UAE Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2015-2020)
Figure 59. Global Endoscopic Retrograde Cholangiopancreatography Revenue Share by Type (2015-2020)
Figure 60. Global Endoscopic Retrograde Cholangiopancreatography Revenue Share by Type in 2019
Figure 61. Global Endoscopic Retrograde Cholangiopancreatography Market Share Forecast by Type (2021-2025)
Figure 62. Global Endoscopic sphincterotomy Revenue Growth Rate (2015-2020)
Figure 63. Global Removal of stones or other biliary debris Revenue Growth Rate (2015-2020)
Figure 64. Global Insertion of bile duct stent(s) Revenue Growth Rate (2015-2020)
Figure 65. Global Dilation of strictures Revenue Growth Rate (2015-2020)
Figure 66. Global Endoscopic Retrograde Cholangiopancreatography Revenue Share by Application (2015-2020)
Figure 67. Global Endoscopic Retrograde Cholangiopancreatography Revenue Share by Application in 2019
Figure 68. Global Endoscopic Retrograde Cholangiopancreatography Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 70. Global Clinics Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Endoscopic Retrograde Cholangiopancreatography Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Endoscopic Retrograde Cholangiopancreatography Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Endoscopic Retrograde Cholangiopancreatography Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Endoscopic Retrograde Cholangiopancreatography Revenue Market Forecast (2021-2025)
Figure 76. Europe Endoscopic Retrograde Cholangiopancreatography Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Revenue Market Forecast (2021-2025)
Figure 78. South America Endoscopic Retrograde Cholangiopancreatography Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel